ArticleBMC cancer2017

Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.

Shivashankar Damodaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.